Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors

MLA

Silber, Jeffrey H., et al. “Design and Baseline Characteristics for the ACE Inhibitor After Anthracycline (AAA) Study of Cardiac Dysfunction in Long-Term Pediatric Cancer Survivors.” American Heart Journal, vol. 142, no. 4, Oct. 2001, p. 577. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.80571321&authtype=sso&custid=ns315887.

APA

Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowsky, M., Kimball, T. R., DeLaat, C., Steinherz, L. J., Zhao, H., & Tartaglione, M. R. (2001). Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors. American Heart Journal, 142(4), 577.

Chicago

Silber, Jeffrey H., Avital Cnaan, Bernard J. Clark, Stephen M. Paridon, Alvin J. Chin, Jack Rychik, Alexa N. Hogarty, et al. 2001. “Design and Baseline Characteristics for the ACE Inhibitor After Anthracycline (AAA) Study of Cardiac Dysfunction in Long-Term Pediatric Cancer Survivors.” American Heart Journal 142 (4): 577. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.80571321&authtype=sso&custid=ns315887.